Advertisement

Topics

Extended-Release Amantadine Effective for Dyskinesia in PD

12:10 EDT 21 Jun 2017 | Medscape

A phase 3 study shows a once-daily formulation of amantadine is superior to placebo in reducing severity and duration of levodopa-induced dyskinesia in patients with Parkinson's.
Medscape Medical News

Original Article: Extended-Release Amantadine Effective for Dyskinesia in PD

NEXT ARTICLE

More From BioPortfolio on "Extended-Release Amantadine Effective for Dyskinesia in PD"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...